SCHEMBL5508327

SCHEMBL5508327

O=C(O)CCCSCCN1C(=O)CCC[C@@H]1C/C=C(\O)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 7/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5502580 0.90 PTGER4 (0.48) PTGER4
SCHEMBL5757165 0.89 PTGER4 (0.51) PTGER4
SCHEMBL5761562 0.89 PTGER4 (0.51) PTGER4
SCHEMBL14030671 0.84 PTGER4 (0.55) PTGER4
SCHEMBL5761636 0.82 PTGER4 (0.43) PTGER4
SCHEMBL5760403 0.82 PTGER4 (0.38) PTGER4
SCHEMBL5761771 0.79 PTGER4 (0.46) PTGER4
SCHEMBL5757536 0.79 PTGER4 (0.46) PTGER4
SCHEMBL14030627 0.78 PTGER4 (0.62) PTGER4
SCHEMBL14030688 0.78 PTGER4 (0.62) PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761495-A2 PIPERIDINYL PROSTAGLANDIN ANALOGS AS OCULAR HYPOTENSIVE AGENTS Allergan Inc. (US) 2007-03-14 EP claimed
WO-2005121086-A2 PIPERIDINYL PROSTAGLANDIN ANALOGS AS OCULAR HYPOTENSIVE AGENTS ALLERGAN, INC. (US) 2005-12-22 WO claimed